{
    "organizations": [],
    "uuid": "91363b4a19c80c425ed723f4914c4aff579c6295",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-qiagen-q4-loss-per-share-018-inclu/brief-qiagen-q4-loss-per-share-0-18-including-items-idUSASB0C3C4",
    "ord_in_thread": 0,
    "title": "BRIEF-Qiagen Q4 Loss Per Share $0.18 Including Items",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 31 (Reuters) - Qiagen Nv:\n* QIAGEN REPORTS RESULTS FOR FOURTH QUARTER AND FULL-YEAR 2017, ANNOUNCES STAT-DX ACQUISITION AND NEW $200 MILLION SHARE REPURCHASE\n* Q4 SALES ROSE 8 PERCENT TO $396.9 MILLION * Q4 LOSS PER SHARE $0.18 INCLUDING ITEMS * Q4 ADJUSTED EARNINGS PER SHARE $0.43 * REAFFIRMS 2020 MID-TERM TARGETS * Q4 EARNINGS PER SHARE VIEW $0.40 -- THOMSON REUTERS I/B/E/S\n* FOR 2018, EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE TO BE APPROXIMATELY $1.38-$1.40 CER\n* FOR 2018, QIAGEN EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE EXPECTED TO BE REDUCED TO ABOUT $1.31-1.33 CER\n* ORGANIC GROWTH IN NET SALES IS EXPECTED TO BE ABOUT 6-7% CER FOR 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-01T05:24:00.000+02:00",
    "crawled": "2018-02-01T15:20:42.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "qiagen",
        "nv",
        "qiagen",
        "report",
        "result",
        "fourth",
        "quarter",
        "announces",
        "acquisition",
        "new",
        "million",
        "share",
        "repurchase",
        "q4",
        "sale",
        "rose",
        "percent",
        "million",
        "q4",
        "loss",
        "per",
        "share",
        "including",
        "item",
        "q4",
        "adjusted",
        "earnings",
        "per",
        "share",
        "reaffirms",
        "target",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "expects",
        "underlying",
        "growth",
        "adjusted",
        "earnings",
        "per",
        "share",
        "approximately",
        "cer",
        "qiagen",
        "expects",
        "underlying",
        "growth",
        "adjusted",
        "earnings",
        "per",
        "share",
        "expected",
        "reduced",
        "cer",
        "organic",
        "growth",
        "net",
        "sale",
        "expected",
        "cer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}